Clinical Trials Browser

Phase 1/2 × Salivary Gland Adenoma, Pleomorphic × Clear all

NCT00987753 2023-05-25

Study Evaluating the Safety and Tolerability of L-377202

Phase 1/2 Completed

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms